Merus Labs International Inc., commonly referred to as Merus Labs, is a prominent pharmaceutical company headquartered in Canada. Founded in 2014, the company has established a strong presence in the specialty pharmaceuticals sector, focusing on the development and commercialisation of innovative therapies. With operations primarily in North America and Europe, Merus Labs is dedicated to providing high-quality products that address unmet medical needs. Their core offerings include a range of prescription medications, particularly in the areas of dermatology and infectious diseases, distinguished by their unique formulations and delivery methods. Merus Labs has achieved significant milestones, including strategic partnerships and a robust portfolio of proprietary products, positioning itself as a key player in the pharmaceutical industry. The company’s commitment to improving patient outcomes underscores its reputation for excellence and innovation in healthcare.
How does Merus Labs International Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merus Labs International Inc.'s score of 33 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Merus Labs International Inc. reported total carbon emissions of approximately 33,082,013 kg CO2e. This total comprises 0 kg CO2e from Scope 1 emissions, 30,928 kg CO2e from Scope 2 emissions, and about 33,051,085 kg CO2e from Scope 3 emissions. The data reflects a consistent emission profile over the previous years, with no significant changes in the scope breakdown. Merus Labs has not established specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company operates as a current subsidiary, inheriting its emissions data from its parent organisation, which is Merus Labs International Inc. itself, with no additional cascading data from other corporate family members. Overall, while Merus Labs has a clear emissions profile, it currently lacks defined climate commitments or reduction strategies, positioning it within an industry context that increasingly prioritises sustainability and carbon neutrality.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | 30,928 | 00,000 | 00,000 |
| Scope 3 | 33,051,085 | 00,000,000 | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merus Labs International Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.